In this dynamic keynote address, Dr. Pamela McCauley discusses the impact of innovation on individuals, nations, and the global society. She highlights her State Department HIV/AIDS Health Care Service Delivery work as an application example of the critical impact of science and technology innovation. Intertwined in her talk, Dr. McCauley highlights the crucial component of diversity and why successful innovation is dependent on all-inclusive collaboration. She shares high and lows of her own career as well as research-based practical strategies for individuals and organizations to propel their actions into useful products and services, both globally and collaboratively.
DR. PAMELA MCCAULEY
Innovation Nation: The Critical Impact of Innovation
Tuesday, July 19
Dr. Pamela McCauley is an ergonomics and biomechanics expert, a dynamic keynote speaker, a popular author, and an award-winning professor in the Department of Industrial Engineering and Management Systems at the University of Central Florida where she serves as Director of the Ergonomics Laboratory.
Dr. McCauley is currently on assignment with the U.S. Department of State in her role as a Jefferson Science Fellow. The Jefferson Science Fellowship program serves as an innovative model for engaging the American academic science and engineering communities in U.S. foreign policy. Dr. McCauley is involved in technology assessment and policy, researching the globally critical Ergonomics of Ebola, HIV and Other Infectious Diseases for Healthcare Workers.
She is the author of over 80 technical papers, book chapters, conference proceedings and the internationally best-selling ergonomics textbook; Ergonomics: Foundational Principles, Applications, and Technologies. Many of her leadership, diversity, innovation and STEM education related talks draw from her research-based book Transforming Your STEM Career Through Leadership and Innovation: Inspiration and Strategies for Women as well as her personal story; Winners Don't Quit . . . Today They Call Me Doctor.
DR. MEREDITH DROSBACK
The National Strategic Computing Initiative
Tuesday, July 19
The National Strategic Computing Initiative was launched one year ago asan all-of-government effort to maximize the benefits of high-performancecomputing research, development, and deployment to advance scientificdiscovery and ensure economic competitiveness. The Initiative includesparticipation from the National Science Foundation, Department of Energy,Department of Defense, and eight other Federal departments and agencies.In this presentation, I will share an overview of the Initiative as wellas an update on Federal efforts over the last year and opportunities forengagement with academia and industry.
Dr. Meredith Drosback serves as the Assistant Director for Education andPhysical Sciences and the Science Division Staff Director at the WhiteHouse Office of Science and Technology Policy (OSTP). Her work focuseson improving learning outcomes and opportunities in science, technology,engineering, and mathematics (STEM) education, as well as a variety oftopics across the broader science portfolio, including space science,physical science, forensic science, and the National Strategic ComputingInitiative. She has been at OSTP since 2012 when she joined the officeto work on the Materials Genome Initiative, a multi-agency initiativedesigned to accelerate the discovery, development, and deployment ofadvanced materials. Prior to coming to OSTP, Dr. Drosback served as aCongressional Fellow on the Senate Commerce, Science, and TransportationCommittee, Subcommittee on Science and Space. There her work covered awide range of scientific and STEM education issues relevant to theNational Science Foundation, National Institute of Standards andTechnology, and NASA. Dr. Drosback completed a postdoctoral researchassistantship at the University of Virginia and received her Ph.D. inAstrophysics from the University of Colorado, a M.S. in Physics fromNorth Carolina State University, and a B.S. in Chemistry from DukeUniversity.
DR. HELEN TURNER
'A'ohe pau ka 'ike i ka hālau ho'okahi: education at the interface of science, culture and privilege in Hawai'i
Wednesday, July 20
Dr. Helen Turner is Chaminade University's Dean of Natural Sciences and a tenured Professor of Biology. Dr. Helen Turner, a leading STEM advocate, has agreed to give a plenary presentation at XSEDE16 in Miami. Her talk title is: "Big Data, Small School: Bringing Data Science to Disenfranchised STEM Students in a Minority Serving Institution."
Turner resides as the Dean of Natural Sciences and is a tenured Professor of Biology at Chaminade University of Honolulu. She moved to Hawai`i in 2000 to take a position as Associate Director of Research at The Queen's Medical Center. In 2007, she joined Chaminade where she has been the major architect of its STEM transformation and has led the initial development of its School of Nursing. In addition, Turner holds joint appointments at the University of Hawaii (UH) School of Medicine and graduate faculty appointments in several UH programs.
An acknowledged leader in Hawaii's science and educational development, Turner has led a number of critical statewide and national partnerships that benefit Chaminade's mission. Chaminade occupies a unique position in the American educational spectrum serving disenfranchised and disadvantaged students from indigenous Hawaiian and Pacific Island backgrounds.
Under her Deanship, Chaminade has made an institutional transformation from a teaching institution with no research capacity to a vibrant culture of undergraduate research. In her laboratory, and those of the faculty she has recruited to Chaminade to share in this mission, these students are no longer denied opportunities to become scientists, health practitioners and educators. Their emerging success in gaining entry to graduate school and health professional programs will have a striking impact on their communities. Turner is committed to using research and inquiry in Chaminade's laboratories as a vehicle to achieve this social change.
Turner earned her PhD at the University of London and performed post-doctoral work at Harvard Medical School as a Wellcome Trust International Prize Fellow.